Policy statement - Rabies-prevention policy update: New reduced-dose schedule

Academic Article

Abstract

  • The Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention recommends reducing the number of doses from 5 to 4 of human diploid cell vaccine or purified chick embryo cell vaccine required for postexposure prophylaxis to prevent rabies in humans. The vaccine doses should be given on day 0 (first day of prophylaxis) and days 3, 7, and 14 after the first dose. For persons with immune suppression, the 5-dose regimen should continue to be used. Recommendations for the use of human rabies immunoglobulin remain unchanged. The American Academy of Pediatrics endorses these recommendations. Copyright © 2011 by the American Academy of Pediatrics.
  • Published In

  • Pediatrics  Journal
  • Digital Object Identifier (doi)

    Author List

  • Brady MT; Bernstein HH; Byington CL; Edwards KM; Fisher MC; Glode MP; Jackson MA; Keyserling HL; Kimberlin DW; Maldonado YA
  • Start Page

  • 785
  • End Page

  • 787
  • Volume

  • 127
  • Issue

  • 4